Newsroom

Sorted by: Latest

-

FDA Panel Reiterates the Cancer Risks of Talc

WASHINGTON--(BUSINESS WIRE)--A panel of medical experts convened by the U.S. Food & Drug Administration urged the agency to study and adopt new standards to prohibit the use of talc in consumer products such as gum, candy, rice and pharmaceuticals. Many of the experts cited the more than 30 years of studies showing an association between talc use and ovarian cancer, which led Johnson & Johnson (NYSE:JNJ) to remove the company’s iconic body powders from the market in recent years. “It’s...
-

AtriCure to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Goldman Sachs 46th Annual Global Healthcare Conference. AtriCure’s management is scheduled to host a fireside chat on Monday, June 9, 2025, at 4:00 p.m. Eastern Standard Time. Interested parties may acc...
-

Wolfspeed Appoints Industry Veteran Dr. David Emerson as Chief Operating Officer

DURHAM, N.C.--(BUSINESS WIRE)--Wolfspeed, Inc. (NYSE: WOLF) (“Wolfspeed” or the “Company”) today announced that David Emerson, Ph.D. has been appointed Executive Vice President and Chief Operating Officer, a newly created role responsible for overseeing operational excellence across the Company’s 200-millimeter facility footprint, reducing customer lead times, and manufacturing leading silicon carbide solutions for Wolfspeed’s customers. Dr. Emerson will be responsible for Wolfspeed’s Operation...
-

Jamieson Wellness Inc. Announces Redemption of Series A Preference Shares

TORONTO--(BUSINESS WIRE)--Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) today announced that it will redeem its outstanding 2,527,121 Series A Preference Shares (the “Preference Shares”) currently held by an affiliate of DCP Capital Partners (“DCP”) in connection with DCP’s 2023 investment in the Company’s Chinese business. The redemption will be effective on or about June 4, 2025 (the “Redemption Date”) and will be completed at a price of $40.19 per Preference Share...
-

Astria Therapeutics to Present at Upcoming C1 Inhibitor Deficiency and Angioedema Workshop

BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present at the 14th C1 Inhibitor Deficiency and Angioedema Workshop in Budapest, Hungary on May 31, 2025. Dr. Marc A. Riedl, Professor of Medicine and Clinical Director of the U.S. HAEA Angioedema Center at the University of California, San Diego, will present safety and efficacy data from...
-

SureWerx Announces Strategic Leadership Transition to Drive Future Growth

CHICAGO--(BUSINESS WIRE)--SureWerx, a leading global manufacturer of personal protective equipment, safety products, tool and safety solutions today announced the appointment of Scott Dowell to Chief Executive Officer, effective May 27, 2025. Dowell will lead SureWerx’s global operations, reinforcing the company’s strategic vision and priorities while driving business performance and a continued focus on innovation, digitization and growth. Dowell succeeds Chris Baby, who is transitioning into...
-

Available Now - Perfect Corp. Debuts New GenAI Clothes Virtual Try-On for Brand and Retailer Websites, Apps and API

NEW YORK--(BUSINESS WIRE)--Perfect Corp. (NYSE: PERF), the global leader in AI and AR beauty and fashion technology and creator of the billion-download YouCam app suite, has announced the launch of AI Clothes Try-on, a next generation of Generative AI-powered experience that reimagines virtual fashion shopping. With just one photo, consumers can now explore endless outfit possibilities by virtually try on entire outfits collection, variant fabrics, and colors in seconds. Styling uncertainty is...
-

Autobahn Therapeutics Announces Presentation of ABX-002 Phase 1 Clinical Results at the 2025 ASCP Annual Meeting

SAN DIEGO--(BUSINESS WIRE)--Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders, today announced the company will present the clinical results from its completed Phase 1 trial of ABX-002 at the 2025 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting, taking place May 27-30, 2025, in Scottsdale, AZ. ABX-002 is a highly potent, oral, thyroid hormone beta receptor (TRβ) selective...
-

Rent-A-Center Opens New Store in Harlan, Kentucky; Grand Opening Celebration Scheduled on May 30

PLANO, Texas--(BUSINESS WIRE)--Upbound Group, Inc. (the "Company" or "Upbound") (NASDAQ: UPBD), a technology and data-driven leader in accessible and inclusive financial solutions that address the evolving needs and aspirations of underserved consumers, has announced the opening of a new Rent-A-Center franchise store in Harlan, Kentucky. The new Rent-A-Center store is located at 168 Village Center Rd., Suite 163, and is open from 10 a.m.-6 p.m. Mondays through Fridays and 9 a.m.-6 p.m. on Satur...
-

Peak Claims Group Partners with Canopy Weather to Enhance Peak Triage Platform

MOBILE, Ala.--(BUSINESS WIRE)--Peak Claims Group, a leading independent claims management firm, is proud to announce a strategic integration with Canopy Weather, a premier provider of hyper-localized weather analytics. This collaboration enhances Peak Claims Group’s proprietary Peak Triage platform, reinforcing the company’s commitment to smarter, faster, and more efficient claims handling through data-driven decision-making. Peak Triage is a proprietary claims approach that leverages real-time...